204 results
Page 7 of 11
6-K
EX-99.1
bksq9xmg
20 Apr 16
RepliCel Life Sciences Finishes Enrolment for its Tendon Repair and Skin Rejuvenation Clinical Trials
12:00am
6-K
EX-99.1
8rjo8kj 98cvibw54v
6 Apr 16
Replicel Life Sciences Announces Restructuring, Cost Reductions and Closing
12:00am
6-K
EX-99.1
4ozs7dv8d n4k1rm
20 Oct 15
First Participants Enrolled in RepliCel's Phase 1 Clinical Trial of its RCS-01 Dermatology Injectable
12:00am
6-K
EX-99.1
p0b5wsdticr1v2
23 Jul 15
RepliCel Receives Two Important Approvals for Dermal Rejuvenation Clinical Trial
12:00am
6-K
EX-99.1
ge22q lp68axjzi
23 Feb 15
RepliCel Submits Clinical Trial Application for its Dermatological Product
12:00am
6-K
EX-99.1
idd09fb hkikf
21 Jan 15
RepliCel Life Sciences to Present at 11th Annual Phacilitate Cell & Gene Therapy Forum in Washington, DC
12:00am
6-K
EX-99.1
kjm 61d7hl6mobutazm3
7 Jan 15
RepliCel Life Sciences to Present at Biotech Showcase 2015 in San Francisco
12:00am
6-K
EX-99.1
e5und6
22 Dec 14
Current report (foreign)
12:00am
6-K
EX-99.1
rmw39
1 Dec 14
RepliCel Life Sciences Receives Health Canada Clearance for Clinical Trial in Patients with Chronic Achilles Tendinosis
12:00am
6-K
EX-99.1
iddyxnv5s5lbyo0t isd
26 Nov 14
RepliCel Announces 2014 Third Quarter Financial Results
12:00am
6-K
EX-99.1
fami94fjn4y bxunmny
29 Oct 14
RepliCel Submits Clinical Trial Application to Health Canada for its Chronic Achilles Tendinosis Trial
12:00am
6-K
EX-99.1
9c7j2upxa10h4gd3k4
9 Oct 14
RepliCel to Present Commercial and Clinical Update at BioJapan 2014 World Business Forum
12:00am
6-K
EX-99.1
6hjxcl
7 Oct 14
RepliCel Life Sciences Adds Industry Specialist to Management Team
12:00am
6-K
EX-99.1
phx7 ovs9
2 Oct 14
Replicel Life Sciences 6-K
12:00am
6-K
EX-99.1
syn ck9lwrx6s
15 Sep 14
Replicel Life Sciences 6-K
12:00am
6-K
EX-99.1
ob1w 3owknyfpl
9 Sep 14
Replicel Life Sciences Inc. 6-K
12:00am
6-K
EX-99.1
ia01swaunuje
4 Sep 14
RepliCel to Present at Rodman & Renshaw’s 16th Annual
12:00am
6-K
EX-99.1
mgaokf4yd
3 Sep 14
RepliCel Life Sciences Joins Centre for Commercialization of Regenerative Medicine, Industry Consortium
12:00am